These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1993962)

  • 1. Cerebral blood flow velocity after surfactant instillation in preterm infants.
    van de Bor M; Ma EJ; Walther FJ
    J Pediatr; 1991 Feb; 118(2):285-7. PubMed ID: 1993962
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cerebral blood flow velocity after surfactant instillation in preterm infants].
    Latini G
    Pediatr Med Chir; 1991; 13(4):439-40. PubMed ID: 1754482
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute effects of synthetic surfactant replacement on pulmonary blood flow in neonatal respiratory distress syndrome.
    Seppänen M; Kääpä P; Kero P
    Am J Perinatol; 1994 Nov; 11(6):382-5. PubMed ID: 7857426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant.
    Abbasi S; Bhutani VK; Gerdes JS
    J Pediatr; 1993 Mar; 122(3):446-52. PubMed ID: 8441104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing surfactant products.
    Prevost RR
    Clin Pharm; 1991 Dec; 10(12):909, 911. PubMed ID: 1773577
    [No Abstract]   [Full Text] [Related]  

  • 6. Colfosceril palmitate (Exosurf)--artificial surfactant for immature lungs.
    Drug Ther Bull; 1991 Jun; 29(12):46. PubMed ID: 1935584
    [No Abstract]   [Full Text] [Related]  

  • 7. Respiratory distress syndrome in New Zealand: evidence from the OSIRIS trial of exogenous surfactant (Exosurf).
    Wach R; Darlow B; Bourchier D; Broadbent R; Knight D; Selby R
    N Z Med J; 1994 Jun; 107(980):234-7. PubMed ID: 8208494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surfactant replacement therapy: issues related to currently available preparations.
    Bose G
    Neonatal Netw; 1992 Jun; 11(4):vii-xii. PubMed ID: 1608367
    [No Abstract]   [Full Text] [Related]  

  • 9. Changes in pulmonary artery pressure in infants with respiratory distress syndrome following treatment with Exosurf.
    Hamdan AH; Shaw NJ
    Arch Dis Child Fetal Neonatal Ed; 1995 May; 72(3):F176-9. PubMed ID: 7796233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Robertson B; Sangstad OD
    Tidsskr Nor Laegeforen; 1994 Feb; 114(5):590-1. PubMed ID: 8209345
    [No Abstract]   [Full Text] [Related]  

  • 11. Pulmonary mechanics and energetics in preterm infants who had respiratory distress syndrome treated with synthetic surfactant.
    Bhutani VK; Abbasi S; Long WA; Gerdes JS
    J Pediatr; 1992 Feb; 120(2 Pt 2):S18-24. PubMed ID: 1735846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pump administration of exogenous surfactant: effects on oxygenation, heart rate, and chest wall movement of premature infants.
    Sitler CG; Turnage CS; McFadden BE; Smith EO; Adams JM
    J Perinatol; 1993; 13(3):197-200. PubMed ID: 8345382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary mechanics in ventilated preterm infants with respiratory distress syndrome after exogenous surfactant administration: a comparison between two surfactant preparations.
    Choukroun ML; Llanas B; Apere H; Fayon M; Galperine RI; Guenard H; Demarquez JL
    Pediatr Pulmonol; 1994 Nov; 18(5):273-8. PubMed ID: 7898964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.
    Stenson BJ; Glover RM; Parry GJ; Wilkie RA; Laing IA; Tarnow-Mordi WO
    Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F19-24. PubMed ID: 8117122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled trial of a single dose of synthetic surfactant at birth in premature infants weighing 500 to 699 grams. The American Exosurf Neonatal Study Group I.
    Stevenson D; Walther F; Long W; Sell M; Pauly T; Gong A; Easa D; Pramanik A; LeBlanc M; Anday E
    J Pediatr; 1992 Feb; 120(2 Pt 2):S3-12. PubMed ID: 1735849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose surfactant rescue therapy in neonatal respiratory distress syndrome.
    Sanghvi KP; Merchant RH
    Indian Pediatr; 1998 Jun; 35(6):533-6. PubMed ID: 10216648
    [No Abstract]   [Full Text] [Related]  

  • 17. OSIRIS trial.
    Tarnow-Mordi W
    Lancet; 1993 Jan; 341(8838):174. PubMed ID: 8093765
    [No Abstract]   [Full Text] [Related]  

  • 18. Criteria for use of colfosceril (Exosurf) in neonates.
    Bhatt-Mehta V; Schumacher RE
    Clin Pharm; 1992 Apr; 11(4):355-7. PubMed ID: 1563234
    [No Abstract]   [Full Text] [Related]  

  • 19. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postnatal changes in pulmonary mechanics and energetics of infants with respiratory distress syndrome following surfactant treatment.
    Bhutani VK; Bowen FW; Sivieri EM
    Biol Neonate; 2005; 87(4):323-31. PubMed ID: 15985755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.